国产雷帕霉素药物涂层支架治疗冠心病合并糖尿病32例(2)

http://www.100md.com 2010年3月25日 轲利东,吴海艳,许春艳,李宏伟,王兴华,杜明华,樊宏杰,孙本琴,韩雪玲

第1页

    参见附件(1408KB，2页)。

     [4]West NE,Ruygrok PN,Disco CM,et al.Clinical and angiographic predictors of restenosis after stent deployment in diabetic patients[J].Circulation,2004,109(7):867-873.

    [5]Moussa I,Leon MB,Baim DS,et al.Impact of sirolimus-eluting stents on outcomein diabetic patients:a SIRIUS (SIRolImUS-coated Bx Velocity balloon-expandable stent in the trentment of patients with de novo coronary artery lesions) substudy[J].Circulation,2004,109(19):2273-2278.

    [6]Stone GW, Ellis SG,Cox DA,et al.A polymer-based,paclitaxel-eluting stent in patients with coronary artery disease[J].N Engl J Med,2004,350(3):221-231.

    [7]Moses JW,Leon MB,Popma JJ,et al.Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery[J].N Engl J Med,2003,349(14):1315-1323.

    [8]Nishio K,Sakurai M,Kusuyama T,et al.A randomized comparison of pioglitazone to inhibit restenosis after coronary stenting in patients with type 2 diabetes[J].Diabetes Care,2006,29(1):101-106.

    (收稿日期:2010-03-11)

    http://www.100md.com/html/paper/1674-4721/2010/09/47-1.htm

您现在查看是摘要介绍页，详见PDF附件(1408KB，2页)。